Key Highlights FDA approval and US launch of generic Saxenda (liraglutide injection) First-ever generic GLP-1 indicated for weight loss in the US market Teva's fifth first-to-market generic launch this year Indicated for adults with obesity or overweight and pediatric patients (12-17 years) with obesity Incidence and Prevalence Global Prevalence of Obesity: Latest Estimates The prevalence of obesity is increasing globally, with a particularly significant rise observed over the past decades in Western and Westernizing countries where rates have more than doubled in the last decade
Glutathione helps your body produce red blood cells and is a good treatment post-stroke and various types of injuries
Senescence -galactosidase [488] by fluorogenic probes
What evidence exists for Ozempic's effects on autoimmune conditions
The enrollment period lasted from August 30, 2019, to March 20, 2020, and follow-up was completed on January 13, 2021.The participants were divided into four groups in a 1:1:1:1 ratio
Zhong S, Chen W, Wang B, Gao C, Liu X, Song Y, et al